Last $20.80 USD
Change Today +0.17 / 0.82%
Volume 544.7K
SRPT On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 2:07 PM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for sarepta therapeutics inc (SRPT)

Year over year, Sarepta Therapeutics, Inc. has seen revenues shrink from $37.3M USD to $14.2M USD, though the company was able to grow net income from a loss of $121.3M USD to a smaller loss of $112.0M USD.
Currency in
Millions of US Dollars
As of:Dec 31
2010
Reclassified
Dec 31
2011
Reclassified
Dec 31
2012
Reclassified
Dec 31
2013
4 Year
Trend
Revenues29.447.037.314.2
TOTAL REVENUES29.447.037.314.2
Cost of Goods Sold--66.452.372.5
GROSS PROFIT29.4-19.4-15.0-58.3
Selling General & Admin Expenses, Total14.415.514.531.2
R&D Expenses36.0------
OTHER OPERATING EXPENSES, TOTAL50.415.514.531.2
OPERATING INCOME-20.9-34.8-29.5-89.5
Interest Expense-0.1-0.1-0.1-0.1
Interest and Investment Income0.40.70.40.2
NET INTEREST EXPENSE0.30.60.30.1
Other Non-Operating Income (Expenses)-11.533.0-91.8-21.8
EBT, EXCLUDING UNUSUAL ITEMS-32.2-1.2-121.1-111.2
Merger & Restructuring Charges---1.1-0.2-0.8
EBT, INCLUDING UNUSUAL ITEMS-32.2-2.3-121.3-112.0
Earnings from Continuing Operations-32.2-2.3-121.3-112.0
NET INCOME-32.2-2.3-121.3-112.0
NET INCOME TO COMMON INCLUDING EXTRA ITEMS-32.2-2.3-121.3-112.0
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS-32.2-2.3-121.3-112.0
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SRPT:US $20.80 USD +0.17

SRPT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AstraZeneca PLC 4,392 GBp -32.50
Baxter International Inc $76.50 USD -0.50
Gilead Sciences Inc $89.49 USD -1.05
Hemispherx Biopharma Inc $0.27 USD +0.0015
SciClone Pharmaceuticals Inc $5.18 USD +0.12
View Industry Companies
 

Industry Analysis

SRPT

Industry Average

Valuation SRPT Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 51.0x
Price/Book 3.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 40.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SAREPTA THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.